News & Updates
Filter by Specialty:

Choline, betaine lower risks of cardiovascular events, recurrent stroke
04 Nov 2021
Plasma choline pathway metabolites, including choline and betaine, appear to reduce the risks of cardiovascular events and recurrent stroke, as well as offer incremental value in risk discrimination and stratification in patients with ischaemic stroke, suggests a recent study.
Choline, betaine lower risks of cardiovascular events, recurrent stroke
04 Nov 2021
Post-ICH antiplatelet therapy not linked to recurrent ICH
28 Oct 2021
byRoshini Claire Anthony
Initiating antiplatelet therapy following an intracerebral haemorrhage (ICH) that occurred during antithrombotic use does not lead to recurrent symptomatic ICH, according to extended results of the RESTART* trial.